microRNA-132 regulates gene expression programs involved in microglial homeostasis
Summary: microRNA-132 (miR-132), a known neuronal regulator, is one of the most robustly downregulated microRNAs (miRNAs) in the brain of Alzheimer’s disease (AD) patients. Increasing miR-132 in AD mouse brain ameliorates amyloid and Tau pathologies, and also restores adult hippocampal neurogenesis...
Main Authors: | Hannah Walgrave, Amber Penning, Giorgia Tosoni, Sarah Snoeck, Kristofer Davie, Emma Davis, Leen Wolfs, Annerieke Sierksma, Mayte Mars, Taofeng Bu, Nicola Thrupp, Lujia Zhou, Diederik Moechars, Renzo Mancuso, Mark Fiers, Andrew J.M. Howden, Bart De Strooper, Evgenia Salta |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-06-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004223009069 |
Similar Items
-
miR‐132 loss de‐represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain
by: Evgenia Salta, et al.
Published: (2016-08-01) -
Novel Alzheimer risk genes determine the microglia response to amyloid‐β but not to TAU pathology
by: Annerieke Sierksma, et al.
Published: (2020-01-01) -
NACC2, a molecular effector of miR-132 regulation at the interface between adult neurogenesis and Alzheimer’s disease
by: Amber Penning, et al.
Published: (2024-09-01) -
The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
by: Hannah Walgrave, et al.
Published: (2021-11-01) -
From Junk to Function: LncRNAs in CNS Health and Disease
by: Rafaela Policarpo, et al.
Published: (2021-07-01)